User_Defined_ID,Accession,Visit,Study_Identifier,Study_Part,Cohort_Group,Treatment,Date_of_Informed_Consent,Date_of_Screening_Visit,Day_of_Screening,Date_of_T1DM_Diagnosis,Day_of_Diagnosis_of_T1DM,Day_0_Date,Enrolled,Enrollment_Date,Safety_Sample,Intent_to_Treat_Sample,Analysis_Sample,Date_of_First_Low_Dose_Infusion,Date_of_First_High_Dose_Infusion,Date_of_Last_Low_Dose_Infusion,Date_of_Last_High_Dose_Infusion,Date_of_Last_Follow-up,Date_of_Primary_Endpoint_Visit,Day_of_Last_Follow-up,Completed_Study_(including_follow-up),Study_Status,Date_of_Study_Termination/Completion,Day_of_Study_Termination,Terminated_Study_Reason,Completed_Study_Drug,Date_of_Study_Drug_Discont./Completion,Day_of_Study_Drug_Discont./Completion,Discontinued_Therapy_Reason,Age_(years),Sex_(Char),Baseline_Height_(cm),Baseline_Weight_(kg),Baseline_BMI_(kg/m^2),Race,Race.1,Ethnicity,Status,Start_Date_of_Adverse_Event,Stop_Date_of_Adverse_Event,Phase_of_AE_occurence,Adverse_Event_Start_Date_Study_Day,Adverse_Event_End_Date_Study_Day,Duration_of_Adverse_Event,Serious_Adverse_Event,Relationship_to_Study_Therapy,Relationship_to_Study_Therapy-_shortened,CTCAE_Grade,CTCAE_Grade_-shortened,Action_Taken_with_Study_Therapy,System_Organ_Class,Preferred_Term,Hypoglycemic_Event,Other_Criteria,_Glucose_conc_55-65mg/dL,Other_Criteria,_Glucose_conc_less_than55_mg/dL,Outcome_of_Adverse_Event,Outcome_of_Adverse_Event-_shortened,Event_is_a_Pregnancy?,Coding_Split_Indicator,Date_AE_became__Serious,Seriousness_for_SAE,_Hospital,Seriousness_for_SAE,_Imp._Med._Event,Awareness_Date,Contrib._Factor_for_SAE,_None,Contrib._Factor_for_SAE,_Accident,Contrib._Factor_for_SAE,_Other,Recent_Study_Therapy_First_Dose_Date,Recent_Study_Therapy_Last_Dose_Date,Last_Dose_Taken_prior_to_SAE,Visit_Number,Data_Snapshot_Date,Number_of_Low_Dose_Infusions,Number_of_High_Dose_Infusions
RETAIN_135342,SUB228868,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-04-17,2010-04-18,-16.0,2010-03-31,-34.0,2010-05-04,Yes,2010-05-04,Yes,Yes,E/I/S,2010-05-04,2010-07-06,2010-06-08,2010-08-10,2012-04-29,2011-05-01,726.0,Yes,Complete,2012-04-29,726.0,,Yes,2010-08-10,98.0,,16.0,Female,168.9,69.2,24.257542185,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-03,2011-03-03,Follow-Up,303.0,303.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_135342,SUB228868,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-04-17,2010-04-18,-16.0,2010-03-31,-34.0,2010-05-04,Yes,2010-05-04,Yes,Yes,E/I/S,2010-05-04,2010-07-06,2010-06-08,2010-08-10,2012-04-29,2011-05-01,726.0,Yes,Complete,2012-04-29,726.0,,Yes,2010-08-10,98.0,,16.0,Female,168.9,69.2,24.257542185,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-06,2011-04-14,Follow-Up,337.0,345.0,8.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Infections_and_infestations,Tooth_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_135342,SUB228868,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-04-17,2010-04-18,-16.0,2010-03-31,-34.0,2010-05-04,Yes,2010-05-04,Yes,Yes,E/I/S,2010-05-04,2010-07-06,2010-06-08,2010-08-10,2012-04-29,2011-05-01,726.0,Yes,Complete,2012-04-29,726.0,,Yes,2010-08-10,98.0,,16.0,Female,168.9,69.2,24.257542185,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-07,2011-04-07,Follow-Up,338.0,338.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_135342,SUB228868,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-04-17,2010-04-18,-16.0,2010-03-31,-34.0,2010-05-04,Yes,2010-05-04,Yes,Yes,E/I/S,2010-05-04,2010-07-06,2010-06-08,2010-08-10,2012-04-29,2011-05-01,726.0,Yes,Complete,2012-04-29,726.0,,Yes,2010-08-10,98.0,,16.0,Female,168.9,69.2,24.257542185,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-05,2011-06-05,Follow-Up,397.0,397.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_135342,SUB228868,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-04-17,2010-04-18,-16.0,2010-03-31,-34.0,2010-05-04,Yes,2010-05-04,Yes,Yes,E/I/S,2010-05-04,2010-07-06,2010-06-08,2010-08-10,2012-04-29,2011-05-01,726.0,Yes,Complete,2012-04-29,726.0,,Yes,2010-08-10,98.0,,16.0,Female,168.9,69.2,24.257542185,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-05,2011-10-06,Follow-Up,397.0,520.0,123.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Back_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_135342,SUB228868,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-04-17,2010-04-18,-16.0,2010-03-31,-34.0,2010-05-04,Yes,2010-05-04,Yes,Yes,E/I/S,2010-05-04,2010-07-06,2010-06-08,2010-08-10,2012-04-29,2011-05-01,726.0,Yes,Complete,2012-04-29,726.0,,Yes,2010-08-10,98.0,,16.0,Female,168.9,69.2,24.257542185,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-28,2011-12-28,Follow-Up,603.0,603.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_135342,SUB228868,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-04-17,2010-04-18,-16.0,2010-03-31,-34.0,2010-05-04,Yes,2010-05-04,Yes,Yes,E/I/S,2010-05-04,2010-07-06,2010-06-08,2010-08-10,2012-04-29,2011-05-01,726.0,Yes,Complete,2012-04-29,726.0,,Yes,2010-08-10,98.0,,16.0,Female,168.9,69.2,24.257542185,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-10,2012-03-10,Follow-Up,676.0,676.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-04,2011-05-05,Washout,70.0,71.0,1.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Pyrexia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-05,2011-05-11,Washout,71.0,77.0,6.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Cough,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-04,2011-06-13,High_Dose,101.0,110.0,9.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Nasal_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-19,2011-12-19,Follow-Up,299.0,299.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-03,2011-11-03,Follow-Up,253.0,253.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-18,2012-05-27,Follow-Up,450.0,459.0,9.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Infections_and_infestations,Streptococcal_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-30,2012-05-30,Follow-Up,462.0,462.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-04-23,2012-04-23,Follow-Up,425.0,425.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-23,2012-07-23,Follow-Up,516.0,516.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-25,2012-05-25,Follow-Up,457.0,457.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-15,2012-05-02,Follow-Up,295.0,434.0,139.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Respiratory,_thoracic_and_mediastinal_disorders,Rhinitis_allergic,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-11,2012-11-11,Follow-Up,627.0,627.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-30,2012-12-30,Follow-Up,676.0,676.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-01-22,2013-01-22,Follow-Up,699.0,699.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-01-29,2013-01-29,Follow-Up,706.0,706.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_143437,SUB228869,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-01-22,2011-01-28,-26.0,2010-11-18,-97.0,2011-02-23,Yes,2011-02-23,Yes,Yes,E/I/S,2011-02-23,2011-05-11,2011-03-30,2011-06-15,2013-02-21,2012-02-16,729.0,Yes,Complete,2013-02-21,729.0,,Yes,2011-06-15,112.0,,9.0,Female,137.5,35.7,18.882644628,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-02-13,2013-02-13,Follow-Up,721.0,721.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-03,2011-03-03,Screening,-5.0,-5.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-22,2011-03-22,Low_Dose,14.0,14.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-29,2011-03-29,Low_Dose,21.0,21.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-03,2011-04-03,Low_Dose,26.0,26.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-04,2011-04-04,Low_Dose,27.0,27.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-06,2011-04-06,Low_Dose,29.0,29.0,0.0,No,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-14,2011-04-14,Washout,37.0,37.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-15,2011-04-15,Washout,38.0,38.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-16,2011-04-16,Washout,39.0,39.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-01,2011-05-01,Washout,54.0,54.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-19,2011-04-19,Washout,42.0,42.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-05,2011-05-26,Washout,58.0,79.0,21.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-18,2011-05-18,High_Dose,71.0,71.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-20,2011-05-20,High_Dose,73.0,73.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-21,2011-05-21,High_Dose,74.0,74.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-09,2011-07-09,Follow-Up,123.0,123.0,0.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-18,2011-08-18,Follow-Up,163.0,163.0,0.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-19,2011-06-02,High_Dose,72.0,86.0,14.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Injection_site_haematoma,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-07,2011-06-07,High_Dose,91.0,91.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Influenza_like_illness,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-16,2011-06-16,High_Dose,100.0,100.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Contusion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-13,2011-07-03,High_Dose,97.0,117.0,20.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-17,2011-09-17,Follow-Up,193.0,193.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-01,2011-12-01,Follow-Up,268.0,268.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Gastroenteritis_viral,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-31,2011-12-31,Follow-Up,298.0,298.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-02,2012-01-02,Follow-Up,300.0,300.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-07,2012-01-07,Follow-Up,305.0,305.0,0.0,No,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-09,2012-01-09,Follow-Up,307.0,307.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-28,2012-01-28,Follow-Up,326.0,326.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-30,2012-01-30,Follow-Up,328.0,328.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-03,2012-02-03,Follow-Up,332.0,332.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-14,2012-02-14,Follow-Up,343.0,343.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-19,2012-02-19,Follow-Up,348.0,348.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-05,2012-05-07,Follow-Up,424.0,426.0,2.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-05,2012-05-05,Follow-Up,424.0,424.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Renal_and_urinary_disorders,Ketonuria,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-19,2012-03-19,Follow-Up,377.0,377.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-06-28,2012-06-28,Follow-Up,478.0,478.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-09-10,2012-10-09,Follow-Up,552.0,581.0,29.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-09-30,2012-10-09,Follow-Up,572.0,581.0,9.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Infections_and_infestations,Sinusitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-12,2012-11-12,Follow-Up,615.0,615.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Renal_and_urinary_disorders,Ketonuria,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-13,2012-11-13,Follow-Up,616.0,616.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Renal_and_urinary_disorders,Ketonuria,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-27,2012-10-27,Follow-Up,599.0,599.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-08,2012-11-08,Follow-Up,611.0,611.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-01-15,2013-01-15,Follow-Up,679.0,679.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-02-25,2013-02-25,Follow-Up,720.0,720.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_168164,SUB228870,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-7.0,2010-12-20,-78.0,2011-03-08,Yes,2011-03-08,Yes,Yes,E/I/S,2011-03-08,2011-05-12,2011-04-12,2011-06-16,2013-03-07,2012-02-28,730.0,Yes,Complete,2013-03-07,730.0,,Yes,2011-06-16,100.0,,11.0,Male,151.0,35.9,15.744923468,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-02-14,2013-02-14,Follow-Up,709.0,709.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-01-24,2011-02-10,Follow-Up,10.0,27.0,17.0,No,Probably_Related,Probably,Grade_2_(Moderate),2,Discontinued,Skin_and_subcutaneous_tissue_disorders,Rash,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-04-13,2011-05-13,Follow-Up,89.0,119.0,30.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Skin_and_subcutaneous_tissue_disorders,Rash,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-06-10,2011-06-10,Follow-Up,147.0,147.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-06-29,2011-06-29,Follow-Up,166.0,166.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-07-02,2011-07-02,Follow-Up,169.0,169.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-07-09,2011-07-09,Follow-Up,176.0,176.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-07-21,2011-07-21,Follow-Up,188.0,188.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-09-27,2011-10-01,Follow-Up,256.0,260.0,4.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Respiratory,_thoracic_and_mediastinal_disorders,Nasal_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-09-28,2011-09-30,Follow-Up,257.0,259.0,2.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Rash,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-09-23,2011-09-23,Follow-Up,252.0,252.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-09-28,2011-09-28,Follow-Up,257.0,257.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-09-29,2011-09-29,Follow-Up,258.0,258.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-10-03,2011-10-03,Follow-Up,262.0,262.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-09-27,2011-10-01,Follow-Up,256.0,260.0,4.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Respiratory,_thoracic_and_mediastinal_disorders,Cough,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-03-26,2011-03-26,Follow-Up,71.0,71.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-04-01,2011-04-01,Follow-Up,77.0,77.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-04-21,2011-04-21,Follow-Up,97.0,97.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2011-05-10,2011-05-10,Follow-Up,116.0,116.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-02-29,2012-02-29,Follow-Up,411.0,411.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-04-07,2012-04-08,Follow-Up,449.0,450.0,1.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Respiratory,_thoracic_and_mediastinal_disorders,Upper-airway_cough_syndrome,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-05-17,2012-05-17,Follow-Up,489.0,489.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-07-13,2012-07-13,Follow-Up,546.0,546.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-08-19,2012-08-19,Follow-Up,583.0,583.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-08-30,2012-08-30,Follow-Up,594.0,594.0,0.0,No,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-10-19,2012-10-19,Follow-Up,644.0,644.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-11-05,2012-11-05,Follow-Up,661.0,661.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-12-16,2012-12-16,Follow-Up,702.0,702.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-12-21,2012-12-21,Follow-Up,707.0,707.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-12-26,2012-12-26,Follow-Up,712.0,712.0,0.0,Yes,Unrelated,Unrelated,Grade_4_(Life-threatening),4,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,2012-12-26,,Imp,2013-01-13,Non,,,2011-01-14,2011-01-21,3500,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2013-01-07,2013-01-07,Follow-Up,724.0,724.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_192151,SUB228871,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-12-30,2010-12-30,-15.0,2010-10-10,-96.0,2011-01-14,Yes,2011-01-14,Yes,Yes,E/I/S,2011-01-14,,2011-01-21,,2013-01-11,2012-01-11,728.0,Yes,Complete,2013-01-11,728.0,,No,2011-01-21,7.0,Investigator_Decision,16.0,Male,,72.0,23.781212842,Black_or_African_American,Black_or_African_American,Not_Hispanic_or_Latino,Completed_study,_Discontinued_therapy,2012-12-29,2013-01-06,Follow-Up,715.0,723.0,8.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Arthralgia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,2.0,0.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-12-17,2010-12-17,Screening,-18.0,-18.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-12-26,2010-12-26,Screening,-9.0,-9.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-04,2011-01-04,Low_Dose,0.0,0.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Infusion_site_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-04,2011-01-04,Low_Dose,0.0,0.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-06,2011-01-18,Low_Dose,2.0,14.0,12.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Infusion_site_haematoma,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-06,2011-01-18,Low_Dose,2.0,14.0,12.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Infusion_site_haematoma,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-11,2011-01-11,Low_Dose,7.0,7.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-16,2011-01-16,Low_Dose,12.0,12.0,0.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-13,2011-01-19,Low_Dose,9.0,15.0,6.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Myalgia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-24,2011-02-01,Low_Dose,20.0,28.0,8.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Myalgia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-18,2011-01-18,Low_Dose,14.0,14.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-11,2011-01-11,Low_Dose,7.0,7.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-18,2011-01-18,Low_Dose,14.0,14.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-25,2011-01-25,Low_Dose,21.0,21.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-02-01,2011-02-01,Low_Dose,28.0,28.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-29,2011-01-29,Low_Dose,25.0,25.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-02-09,2011-02-09,Washout,36.0,36.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Rash,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-02-14,2011-02-14,Washout,41.0,41.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-02-16,2011-02-16,Washout,43.0,43.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-02-17,2011-02-17,Washout,44.0,44.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-02-20,2011-02-20,Washout,47.0,47.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-05,2011-03-14,Washout,60.0,69.0,9.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-07,2011-03-08,Washout,62.0,63.0,1.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-03,2011-03-03,Washout,58.0,58.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-10,2011-03-11,High_Dose,65.0,66.0,1.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Skin_and_subcutaneous_tissue_disorders,Rash_pruritic,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-12,2011-03-12,High_Dose,67.0,67.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-21,2011-03-21,High_Dose,76.0,76.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-24,2011-03-24,High_Dose,79.0,79.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-24,2011-03-24,High_Dose,79.0,79.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-24,2011-03-24,High_Dose,79.0,79.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Muscle_spasms,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-29,2011-03-29,High_Dose,84.0,84.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-31,2011-03-31,High_Dose,86.0,86.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-05,2011-04-05,High_Dose,91.0,91.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-13,2011-04-13,High_Dose,99.0,99.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-14,2011-04-20,Follow-Up,100.0,106.0,6.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Infusion_site_haematoma,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-14,2011-04-22,Follow-Up,100.0,108.0,8.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Infusion_site_haematoma,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-18,2011-04-18,Follow-Up,104.0,104.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-23,2011-04-23,Follow-Up,109.0,109.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-24,2011-04-24,Follow-Up,110.0,110.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Rash,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-24,2011-04-27,Follow-Up,110.0,113.0,3.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Skin_and_subcutaneous_tissue_disorders,Rash_pruritic,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-19,2011-04-19,Follow-Up,105.0,105.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-13,2011-04-20,High_Dose,99.0,106.0,7.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Investigations,Fibrin_D_dimer_increased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-21,2011-03-21,High_Dose,76.0,76.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-28,2011-03-28,High_Dose,83.0,83.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-11,2011-04-11,High_Dose,97.0,97.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-03-12,2011-03-16,High_Dose,67.0,71.0,4.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-13,2011-05-13,Follow-Up,129.0,129.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-13,2011-05-13,Follow-Up,129.0,129.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-24,2011-05-24,Follow-Up,140.0,140.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-28,2011-05-28,Follow-Up,144.0,144.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-28,2011-06-04,Follow-Up,144.0,151.0,7.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-13,2011-06-25,Follow-Up,160.0,172.0,12.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-13,2011-06-13,Follow-Up,160.0,160.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-14,2011-06-14,Follow-Up,161.0,161.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-14,2011-06-14,Follow-Up,161.0,161.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-22,2011-07-22,Follow-Up,199.0,199.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-27,2011-07-31,Follow-Up,204.0,208.0,4.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Gastroenteritis_viral,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-27,2011-07-27,Follow-Up,204.0,204.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-06,2011-07-06,Follow-Up,183.0,183.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-04,2011-08-07,Follow-Up,212.0,215.0,3.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-06,2011-08-06,Follow-Up,214.0,214.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-29,2011-08-29,Follow-Up,237.0,237.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-11,2011-08-11,Follow-Up,219.0,219.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-03,2011-09-03,Follow-Up,242.0,242.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-04,2011-09-04,Follow-Up,243.0,243.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-22,2011-07-22,Follow-Up,199.0,199.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Dizziness,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-28,2011-07-28,Follow-Up,205.0,205.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-04,2011-10-04,Follow-Up,273.0,273.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-17,2011-10-17,Follow-Up,286.0,286.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-25,2011-10-25,Follow-Up,294.0,294.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-31,2011-10-31,Follow-Up,300.0,300.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-02,2011-11-02,Follow-Up,302.0,302.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-13,2011-11-18,Follow-Up,313.0,318.0,5.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Respiratory_tract_infection_viral,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-20,2011-11-20,Follow-Up,320.0,320.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-13,2011-11-13,Follow-Up,313.0,313.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Myalgia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-27,2011-11-27,Follow-Up,327.0,327.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-05,2011-12-05,Follow-Up,335.0,335.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Chest_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-12,2011-12-12,Follow-Up,342.0,342.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-13,2011-12-13,Follow-Up,343.0,343.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-24,2011-12-24,Follow-Up,354.0,354.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-15,2011-12-15,Follow-Up,345.0,345.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-18,2011-12-18,Follow-Up,348.0,348.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-24,2012-01-24,Follow-Up,385.0,385.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-14,2012-01-14,Follow-Up,375.0,375.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-16,2012-01-16,Follow-Up,377.0,377.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-01-18,2012-01-18,Follow-Up,379.0,379.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-24,2012-03-31,Follow-Up,445.0,452.0,7.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Infections_and_infestations,Pneumonia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-05,2011-12-05,Follow-Up,335.0,335.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-18,2012-02-20,Follow-Up,410.0,412.0,2.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Procedural_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-20,2011-11-20,Follow-Up,320.0,320.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Myalgia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-01,2012-02-05,Follow-Up,393.0,397.0,4.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Neoplasms_benign,_malignant_and_unspecified_(incl_cysts_and_polyps),Skin_papilloma,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-02,2012-02-02,Follow-Up,394.0,394.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-04,2012-03-04,Follow-Up,425.0,425.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-24,2012-02-24,Follow-Up,416.0,416.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-18,2012-03-18,Follow-Up,439.0,439.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-23,2011-12-23,Follow-Up,353.0,353.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Neoplasms_benign,_malignant_and_unspecified_(incl_cysts_and_polyps),Skin_papilloma,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-24,2011-12-24,Follow-Up,354.0,354.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-24,,Follow-Up,445.0,,,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Pyrexia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-29,2012-03-29,Follow-Up,450.0,450.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Cough,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-04-28,2012-04-29,Follow-Up,480.0,481.0,1.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-13,2012-05-13,Follow-Up,495.0,495.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-13,2012-05-13,Follow-Up,495.0,495.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-20,2012-05-20,Follow-Up,502.0,502.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-21,2012-05-23,Follow-Up,503.0,505.0,2.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-02,2012-07-02,Follow-Up,545.0,545.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-21,2012-05-21,Follow-Up,503.0,503.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-06-16,2012-06-16,Follow-Up,529.0,529.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-06-16,2012-06-16,Follow-Up,529.0,529.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-06-30,2012-06-30,Follow-Up,543.0,543.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-06,2012-07-06,Follow-Up,549.0,549.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-08,2012-07-08,Follow-Up,551.0,551.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-17,2012-07-17,Follow-Up,560.0,560.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-18,2012-07-18,Follow-Up,561.0,561.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-03,2012-08-03,Follow-Up,577.0,577.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-06,2012-08-06,Follow-Up,580.0,580.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-09,2012-08-09,Follow-Up,583.0,583.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-10,2012-08-10,Follow-Up,584.0,584.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-12,2012-08-12,Follow-Up,586.0,586.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-19,2012-08-19,Follow-Up,593.0,593.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-22,2012-08-22,Follow-Up,596.0,596.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-10,2012-08-10,Follow-Up,584.0,584.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Vomiting,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-09-05,2012-09-08,Follow-Up,610.0,613.0,3.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-28,2012-08-28,Follow-Up,602.0,602.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-09-12,2012-09-12,Follow-Up,617.0,617.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-09-17,2012-09-17,Follow-Up,622.0,622.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-09-30,2012-09-30,Follow-Up,635.0,635.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-06,2012-10-06,Follow-Up,641.0,641.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-09,2012-10-09,Follow-Up,644.0,644.0,0.0,No,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-13,2012-10-13,Follow-Up,648.0,648.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-24,2012-10-24,Follow-Up,659.0,659.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-25,2012-10-25,Follow-Up,660.0,660.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-26,2012-10-26,Follow-Up,661.0,661.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-06,2012-11-13,Follow-Up,672.0,679.0,7.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-06,2012-11-15,Follow-Up,672.0,681.0,9.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Cough,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-19,2012-11-19,Follow-Up,685.0,685.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-08,2012-12-09,Follow-Up,704.0,705.0,1.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-10,2012-12-10,Follow-Up,706.0,706.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-14,2012-12-14,Follow-Up,710.0,710.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-19,2012-12-19,Follow-Up,715.0,715.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-22,2012-12-22,Follow-Up,718.0,718.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-23,2012-12-23,Follow-Up,719.0,719.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-01-11,2013-07-16,Follow-Up,738.0,924.0,186.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Endocrine_disorders,Goitre,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_215465,SUB228872,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-12-17,2010-12-17,-18.0,2010-10-02,-94.0,2011-01-04,Yes,2011-01-04,Yes,Yes,E/I/S,2011-01-04,2011-03-09,2011-02-08,2011-04-13,2013-01-11,2011-12-28,738.0,Yes,Complete,2013-01-11,738.0,,Yes,2011-04-18,104.0,,9.0,Female,143.8,37.2,17.989751645,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-28,2013-01-13,Follow-Up,724.0,740.0,16.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Cough,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-13,2010-10-13,Low_Dose,0.0,0.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-18,2010-10-19,Low_Dose,5.0,6.0,1.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Neck_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-22,2010-10-23,Low_Dose,9.0,10.0,1.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-11-03,2010-11-03,Low_Dose,21.0,21.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-11-04,2011-01-26,Low_Dose,22.0,105.0,83.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Foot_fracture,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-11-18,2010-11-20,Washout,36.0,38.0,2.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Diarrhoea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-11-20,2010-11-20,Washout,38.0,38.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Dizziness,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-11-20,2010-11-20,Washout,38.0,38.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-11-23,2010-11-24,Washout,41.0,42.0,1.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-12-24,2010-12-27,High_Dose,72.0,75.0,3.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_discomfort,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-12-24,2010-12-27,High_Dose,72.0,75.0,3.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Chest_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-12-29,2010-12-29,High_Dose,77.0,77.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-01,2011-01-01,High_Dose,80.0,80.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-04,2011-01-04,High_Dose,83.0,83.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Rash,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-11,2011-01-11,High_Dose,90.0,90.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-17,2011-01-19,High_Dose,96.0,98.0,2.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Oropharyngeal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-05,2011-01-05,High_Dose,84.0,84.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-09,2011-10-11,Follow-Up,361.0,363.0,2.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Respiratory,_thoracic_and_mediastinal_disorders,Upper_respiratory_tract_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-22,2011-09-22,Follow-Up,344.0,344.0,0.0,No,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-14,2011-09-14,Follow-Up,336.0,336.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-07,2011-09-07,Follow-Up,329.0,329.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-02,2011-08-18,Follow-Up,293.0,309.0,16.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Upper_respiratory_tract_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-17,2011-06-17,Follow-Up,247.0,247.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-04,2011-06-03,Follow-Up,173.0,233.0,60.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Skin_and_subcutaneous_tissue_disorders,Skin_mass,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-15,,Follow-Up,367.0,,,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Investigations,Glycosylated_haemoglobin_increased,No,,,Ongoing_At_End_Of_Study,Ongoing_at_End,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-31,,Follow-Up,444.0,,,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Musculoskeletal_and_connective_tissue_disorders,Musculoskeletal_pain,No,,,Ongoing_At_End_Of_Study,Ongoing_at_End,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_300339,SUB228873,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-10-05,2010-10-05,-8.0,2010-09-18,-25.0,2010-10-13,Yes,2010-10-13,Yes,Yes,E/I/S,2010-10-13,2010-12-22,2010-11-17,2011-01-26,2012-10-05,2011-10-15,723.0,Yes,Complete,2012-10-05,723.0,,Yes,2011-01-26,105.0,,13.0,Male,,54.0,18.795520401,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-11,2012-04-02,Follow-Up,515.0,537.0,22.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-02,2010-07-02,Screening,-10.0,-10.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-04,2010-07-04,Screening,-8.0,-8.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-05,2010-07-05,Screening,-7.0,-7.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-13,2010-07-13,Low_Dose,1.0,1.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-15,2010-07-15,Low_Dose,3.0,3.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-17,2010-07-17,Low_Dose,5.0,5.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-26,2010-07-26,Low_Dose,14.0,14.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-08-05,2010-08-05,Low_Dose,24.0,24.0,0.0,No,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-08-19,2010-08-19,Washout,38.0,38.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-20,2010-10-27,High_Dose,100.0,107.0,7.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Contusion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-29,2011-04-29,Follow-Up,291.0,291.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-26,2012-06-07,Follow-Up,349.0,696.0,347.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Metabolism_and_nutrition_disorders,Vitamin_D_deficiency,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-14,,Follow-Up,733.0,,,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Dry_skin,No,,,Ongoing_At_End_Of_Study,Ongoing_at_End,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-05,2012-07-06,Follow-Up,724.0,725.0,1.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Gastrointestinal_disorders,Vomiting,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-05,2012-07-06,Follow-Up,724.0,725.0,1.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-12,2011-10-12,Follow-Up,457.0,457.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_350507,SUB228874,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-06-15,2010-06-15,-27.0,2010-05-28,-45.0,2010-07-12,Yes,2010-07-12,Yes,Yes,E/I/S,2010-07-12,2010-09-29,2010-08-16,2010-11-03,2012-07-14,2011-07-04,733.0,Yes,Complete,2012-07-14,733.0,,Yes,2010-11-03,114.0,,13.0,Male,163.5,51.6,19.302527846,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-04,2012-09-06,Follow-Up,357.0,787.0,430.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Investigations,Fibrin_D_dimer_increased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_465679,SUB228875,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-06-06,2010-06-06,-20.0,2010-04-27,-60.0,2010-06-26,Yes,2010-06-26,Yes,Yes,E/I/S,2010-06-26,2010-08-28,2010-07-31,2010-10-02,2010-10-24,,120.0,No,Terminated_early_from_protocol,2011-02-09,228.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2010-10-02,98.0,,19.0,Male,170.1,67.8,23.432631702,White,White,Not_Hispanic_or_Latino,Terminated_from_study,2010-08-27,2010-08-27,Washout,62.0,62.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Infections_and_infestations,Nasopharyngitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_465679,SUB228875,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-06-06,2010-06-06,-20.0,2010-04-27,-60.0,2010-06-26,Yes,2010-06-26,Yes,Yes,E/I/S,2010-06-26,2010-08-28,2010-07-31,2010-10-02,2010-10-24,,120.0,No,Terminated_early_from_protocol,2011-02-09,228.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2010-10-02,98.0,,19.0,Male,170.1,67.8,23.432631702,White,White,Not_Hispanic_or_Latino,Terminated_from_study,2010-08-24,2010-08-26,Washout,59.0,61.0,2.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Nasal_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_465679,SUB228875,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-06-06,2010-06-06,-20.0,2010-04-27,-60.0,2010-06-26,Yes,2010-06-26,Yes,Yes,E/I/S,2010-06-26,2010-08-28,2010-07-31,2010-10-02,2010-10-24,,120.0,No,Terminated_early_from_protocol,2011-02-09,228.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2010-10-02,98.0,,19.0,Male,170.1,67.8,23.432631702,White,White,Not_Hispanic_or_Latino,Terminated_from_study,2010-10-14,2010-10-14,Follow-Up,110.0,110.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_511474,SUB228876,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-14,2010-09-14,-19.0,2010-09-04,-29.0,2010-10-03,Yes,2010-10-03,Yes,Yes,E/I/S,2010-10-03,2010-12-05,2010-11-07,2011-01-09,2012-09-25,2011-09-25,723.0,Yes,Complete,2012-09-25,723.0,,Yes,2011-01-09,98.0,,33.0,Male,180.0,94.2,29.074074074,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-23,2010-10-24,Low_Dose,20.0,21.0,1.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Musculoskeletal_and_connective_tissue_disorders,Arthralgia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_511474,SUB228876,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-14,2010-09-14,-19.0,2010-09-04,-29.0,2010-10-03,Yes,2010-10-03,Yes,Yes,E/I/S,2010-10-03,2010-12-05,2010-11-07,2011-01-09,2012-09-25,2011-09-25,723.0,Yes,Complete,2012-09-25,723.0,,Yes,2011-01-09,98.0,,33.0,Male,180.0,94.2,29.074074074,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-30,2010-11-05,Low_Dose,27.0,33.0,6.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Cough,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_511474,SUB228876,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-14,2010-09-14,-19.0,2010-09-04,-29.0,2010-10-03,Yes,2010-10-03,Yes,Yes,E/I/S,2010-10-03,2010-12-05,2010-11-07,2011-01-09,2012-09-25,2011-09-25,723.0,Yes,Complete,2012-09-25,723.0,,Yes,2011-01-09,98.0,,33.0,Male,180.0,94.2,29.074074074,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-12-07,2010-12-26,High_Dose,65.0,84.0,19.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Rash_papular,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_511474,SUB228876,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-14,2010-09-14,-19.0,2010-09-04,-29.0,2010-10-03,Yes,2010-10-03,Yes,Yes,E/I/S,2010-10-03,2010-12-05,2010-11-07,2011-01-09,2012-09-25,2011-09-25,723.0,Yes,Complete,2012-09-25,723.0,,Yes,2011-01-09,98.0,,33.0,Male,180.0,94.2,29.074074074,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-05-17,,Follow-Up,226.0,,,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Renal_and_urinary_disorders,Hypercalciuria,No,,,Ongoing_At_End_Of_Study,Ongoing_at_End,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_511474,SUB228876,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-14,2010-09-14,-19.0,2010-09-04,-29.0,2010-10-03,Yes,2010-10-03,Yes,Yes,E/I/S,2010-10-03,2010-12-05,2010-11-07,2011-01-09,2012-09-25,2011-09-25,723.0,Yes,Complete,2012-09-25,723.0,,Yes,2011-01-09,98.0,,33.0,Male,180.0,94.2,29.074074074,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-13,2011-04-13,Follow-Up,192.0,192.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_511474,SUB228876,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-14,2010-09-14,-19.0,2010-09-04,-29.0,2010-10-03,Yes,2010-10-03,Yes,Yes,E/I/S,2010-10-03,2010-12-05,2010-11-07,2011-01-09,2012-09-25,2011-09-25,723.0,Yes,Complete,2012-09-25,723.0,,Yes,2011-01-09,98.0,,33.0,Male,180.0,94.2,29.074074074,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-29,2012-08-25,Follow-Up,665.0,692.0,27.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Injury,_poisoning_and_procedural_complications,Fibula_fracture,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-06-27,2011-06-27,Low_Dose,1.0,1.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-07-16,2011-07-16,Low_Dose,20.0,20.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Diarrhoea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-08-06,2011-08-14,Washout,41.0,49.0,8.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Injury,_poisoning_and_procedural_complications,Upper_limb_fracture,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-07-27,2011-07-27,Low_Dose,31.0,31.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-08-21,2011-08-22,Washout,56.0,57.0,1.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Infections_and_infestations,Nasopharyngitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-04,2011-09-11,Washout,70.0,77.0,7.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Eczema,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-09,2011-09-09,High_Dose,75.0,75.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-11,2011-09-11,High_Dose,77.0,77.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-11,2011-09-18,High_Dose,77.0,84.0,7.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Eye_disorders,Conjunctivitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-12,2011-09-16,High_Dose,78.0,82.0,4.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-17,2011-09-17,High_Dose,83.0,83.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-15,2011-09-23,High_Dose,81.0,89.0,8.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Injury,_poisoning_and_procedural_complications,Contusion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-09-19,2011-09-25,High_Dose,85.0,91.0,6.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-10-15,2011-10-16,Follow-Up,111.0,112.0,1.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Abdominal_pain_upper,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-10-15,2011-10-16,Follow-Up,111.0,112.0,1.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Diarrhoea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-01-06,2012-01-06,Follow-Up,194.0,194.0,0.0,No,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-02-18,2012-02-21,Follow-Up,237.0,240.0,3.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Infections_and_infestations,Gastroenteritis_viral,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-02-20,2012-02-20,Follow-Up,239.0,239.0,0.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hyperglycaemia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-04-15,2012-04-15,Follow-Up,294.0,294.0,0.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hyperglycaemia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-05-02,2012-06-17,Follow-Up,311.0,357.0,46.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Injury,_poisoning_and_procedural_complications,Upper_limb_fracture,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-10-20,2012-11-14,Follow-Up,482.0,507.0,25.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Injury,_poisoning_and_procedural_complications,Hand_fracture,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-10-25,2012-10-27,Follow-Up,487.0,489.0,2.0,Yes,Unrelated,Unrelated,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Diabetic_ketoacidosis,No,,,Resolved_Without_Sequelae,Resolved,No,,2012-10-25,Hos,Imp,2012-11-06,,Con,,2011-06-26,2011-10-09,4500,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-09-09,2012-09-15,Follow-Up,441.0,447.0,6.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Concussion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-01-25,2012-02-16,Follow-Up,213.0,235.0,22.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Infections_and_infestations,Upper_respiratory_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-01-03,2012-01-09,Follow-Up,191.0,197.0,6.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-01-03,2012-01-09,Follow-Up,191.0,197.0,6.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-04-13,2012-04-17,Follow-Up,292.0,296.0,4.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Gastrointestinal_disorders,Vomiting,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-04-13,2012-04-17,Follow-Up,292.0,296.0,4.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-09-22,2012-09-22,Follow-Up,454.0,454.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Nervous_system_disorders,Syncope,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-09-22,2012-09-22,Follow-Up,454.0,454.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hyperglycaemia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-05-27,2012-05-29,Follow-Up,336.0,338.0,2.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Infections_and_infestations,Gastroenteritis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-11-19,2012-11-22,Follow-Up,512.0,515.0,3.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-01-31,2012-01-31,Follow-Up,219.0,219.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Vomiting,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-02-20,2012-02-20,Follow-Up,239.0,239.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Renal_and_urinary_disorders,Ketonuria,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-09-01,2012-09-07,Follow-Up,433.0,439.0,6.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Concussion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-09-16,2012-09-16,Follow-Up,448.0,448.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Metabolism_and_nutrition_disorders,Hyperglycaemia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-11-17,2012-11-17,Follow-Up,510.0,510.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-11-06,,Follow-Up,499.0,,,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Investigations,Glycosylated_haemoglobin_increased,No,,,Ongoing_At_End_Of_Study,Ongoing_at_End,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2012-09-09,2012-09-19,Follow-Up,441.0,451.0,10.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Eye_disorders,Conjunctivitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_516891,SUB228877,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-05-29,2011-05-29,-28.0,2011-04-30,-57.0,2011-06-26,Yes,2011-06-26,Yes,Yes,E/I/S,2011-06-26,2011-09-04,2011-07-31,2011-10-09,2012-11-06,2012-07-25,499.0,No,Terminated_early_from_protocol,2013-02-05,590.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-10-09,105.0,,12.0,Male,154.9,43.9,18.296233102,White,Multiple_Races,Not_Hispanic_or_Latino,Terminated_from_study,2011-10-08,2011-10-09,High_Dose,104.0,105.0,1.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Skin_and_subcutaneous_tissue_disorders,Rash,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_615116,SUB228878,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-11-29,2010-11-29,-19.0,2010-09-10,-99.0,2010-12-18,Yes,2010-12-18,Yes,Yes,E/I/S,2010-12-18,2011-03-12,2011-01-22,2011-04-16,2012-12-11,2011-12-13,724.0,Yes,Complete,2012-12-11,724.0,,Yes,2011-04-16,119.0,,13.0,Male,155.3,40.8,16.91676248,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-01,2011-01-08,Low_Dose,14.0,21.0,7.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,Interrupted,Investigations,Fibrin_D_dimer_increased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,5.0,6.0
RETAIN_615116,SUB228878,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-11-29,2010-11-29,-19.0,2010-09-10,-99.0,2010-12-18,Yes,2010-12-18,Yes,Yes,E/I/S,2010-12-18,2011-03-12,2011-01-22,2011-04-16,2012-12-11,2011-12-13,724.0,Yes,Complete,2012-12-11,724.0,,Yes,2011-04-16,119.0,,13.0,Male,155.3,40.8,16.91676248,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-22,2011-03-12,Low_Dose,35.0,84.0,49.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Investigations,White_blood_cell_count_decreased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,5.0,6.0
RETAIN_615116,SUB228878,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-11-29,2010-11-29,-19.0,2010-09-10,-99.0,2010-12-18,Yes,2010-12-18,Yes,Yes,E/I/S,2010-12-18,2011-03-12,2011-01-22,2011-04-16,2012-12-11,2011-12-13,724.0,Yes,Complete,2012-12-11,724.0,,Yes,2011-04-16,119.0,,13.0,Male,155.3,40.8,16.91676248,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-19,2011-06-22,Follow-Up,183.0,186.0,3.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Pyrexia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,5.0,6.0
RETAIN_615116,SUB228878,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2010-11-29,2010-11-29,-19.0,2010-09-10,-99.0,2010-12-18,Yes,2010-12-18,Yes,Yes,E/I/S,2010-12-18,2011-03-12,2011-01-22,2011-04-16,2012-12-11,2011-12-13,724.0,Yes,Complete,2012-12-11,724.0,,Yes,2011-04-16,119.0,,13.0,Male,155.3,40.8,16.91676248,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-24,2011-12-24,Follow-Up,371.0,371.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,Glucose_55-65,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,5.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-03-29,2010-03-30,Low_Dose,2.0,3.0,1.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Pyrexia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-04-22,2010-04-26,Low_Dose,26.0,30.0,4.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Influenza_like_illness,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-04-17,2010-04-25,Low_Dose,21.0,29.0,8.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Investigations,Lymphocyte_count_increased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-04-03,2010-04-10,Low_Dose,7.0,14.0,7.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Contusion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-05-27,2010-05-31,Washout,61.0,65.0,4.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Rhinitis_allergic,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-05-27,2010-05-31,Washout,61.0,65.0,4.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Cough,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-05-08,2010-05-29,Washout,42.0,63.0,21.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Investigations,Neutrophil_count_decreased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-06-05,2010-06-12,High_Dose,70.0,77.0,7.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-07-16,2010-07-25,Follow-Up,111.0,120.0,9.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-06-05,2010-06-12,High_Dose,70.0,77.0,7.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Investigations,Lymphocyte_count_decreased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-06-12,2010-06-19,High_Dose,77.0,84.0,7.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Investigations,Lymphocyte_count_increased,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-06-02,2010-06-12,High_Dose,67.0,77.0,10.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Constipation,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-24,2010-11-03,Follow-Up,211.0,221.0,10.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-10-28,2010-10-28,Follow-Up,215.0,215.0,0.0,No,Probably_Related,Probably,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-01,2011-01-20,Follow-Up,280.0,299.0,19.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Procedural_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-08,2011-01-08,Follow-Up,287.0,287.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Procedural_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-13,2011-01-13,Follow-Up,292.0,292.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Injury,_poisoning_and_procedural_complications,Procedural_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-11-20,2010-11-30,Follow-Up,238.0,248.0,10.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Pharyngitis_streptococcal,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-30,2011-01-30,Follow-Up,309.0,309.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,Y,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-30,2011-02-13,Follow-Up,309.0,323.0,14.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Fungal_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-30,2011-02-13,Follow-Up,309.0,323.0,14.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Renal_and_urinary_disorders,Nephrolithiasis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-01-30,2011-02-13,Follow-Up,309.0,323.0,14.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Pneumonia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-13,2011-06-14,Follow-Up,443.0,444.0,1.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-06-26,2011-07-03,Follow-Up,456.0,463.0,7.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-13,,Follow-Up,473.0,,,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,General_disorders_and_administration_site_conditions,Chest_pain,No,,,Ongoing_At_End_Of_Study,Ongoing_at_End,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-02,2011-12-09,Follow-Up,615.0,622.0,7.0,Yes,Unlikely_Related,Unlikely,Grade_3_(Severe),3,None,Musculoskeletal_and_connective_tissue_disorders,Musculoskeletal_pain,No,,,Resolved_Without_Sequelae,Resolved,No,,2011-12-02,Hos,,2011-12-09,,,Oth,2010-03-27,2010-07-03,5000,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-23,2012-01-12,Follow-Up,636.0,656.0,20.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-30,2012-03-30,Follow-Up,734.0,734.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_703798,SUB228879,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-03-14,2010-03-18,-9.0,2009-12-18,-99.0,2010-03-27,Yes,2010-03-27,Yes,Yes,E/I/S,2010-03-27,2010-05-29,2010-05-01,2010-07-03,2012-03-31,2011-03-25,735.0,Yes,Complete,2012-03-31,735.0,,Yes,2010-07-03,98.0,,17.0,Female,165.1,51.8,19.003588303,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-02-03,2012-02-18,Follow-Up,678.0,693.0,15.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Injury,_poisoning_and_procedural_complications,Radius_fracture,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_731341,SUB228880,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-08-15,2010-08-15,-35.0,2010-06-09,-102.0,2010-09-19,Yes,2010-09-19,Yes,Yes,E/I/S,2010-09-19,2010-11-21,2010-10-24,2010-12-26,2012-10-06,2011-09-22,748.0,Yes,Complete,2012-10-06,748.0,,Yes,2010-12-26,98.0,,18.0,Male,174.2,69.3,22.836888594,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-09-26,2010-09-26,Low_Dose,7.0,7.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_731341,SUB228880,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-08-15,2010-08-15,-35.0,2010-06-09,-102.0,2010-09-19,Yes,2010-09-19,Yes,Yes,E/I/S,2010-09-19,2010-11-21,2010-10-24,2010-12-26,2012-10-06,2011-09-22,748.0,Yes,Complete,2012-10-06,748.0,,Yes,2010-12-26,98.0,,18.0,Male,174.2,69.3,22.836888594,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2010-12-12,2010-12-12,High_Dose,84.0,84.0,0.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Nausea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-07-04,2011-07-04,Follow-Up,275.0,275.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-04-10,2011-07-16,Follow-Up,190.0,287.0,97.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Respiratory_tract_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-03,2011-10-08,Follow-Up,366.0,371.0,5.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Musculoskeletal_and_connective_tissue_disorders,Pain_in_extremity,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-08,2011-10-17,Follow-Up,371.0,380.0,9.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Musculoskeletal_and_connective_tissue_disorders,Arthralgia,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-06-15,2012-06-15,Follow-Up,622.0,622.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-23,2012-07-23,Follow-Up,660.0,660.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-07-24,2012-07-24,Follow-Up,661.0,661.0,0.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-08-22,2012-09-04,Follow-Up,690.0,703.0,13.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Influenza,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-10-02,2012-10-02,Follow-Up,731.0,731.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Nervous_system_disorders,Headache,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_775379,SUB228881,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2010-09-04,2010-09-04,-28.0,2010-08-10,-53.0,2010-10-02,Yes,2010-10-02,Yes,Yes,E/I/S,2010-10-02,2010-12-04,2010-11-06,2011-01-08,2012-10-02,2011-10-03,731.0,Yes,Complete,2012-10-02,731.0,,Yes,2011-01-08,98.0,,23.0,Male,175.5,84.3,27.369907712,White,White,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-06,2012-05-20,Follow-Up,582.0,596.0,14.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Nasopharyngitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-11,2011-08-11,Follow-Up,136.0,136.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-20,2011-08-20,Follow-Up,145.0,145.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-08-17,2011-08-25,Follow-Up,142.0,150.0,8.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Infections_and_infestations,Nasopharyngitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-25,2011-09-25,Follow-Up,181.0,181.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-09-24,2011-10-09,Follow-Up,180.0,195.0,15.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Infections_and_infestations,Nasopharyngitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-28,2011-11-04,Follow-Up,214.0,221.0,7.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Infections_and_infestations,Ear_infection,No,,,Resolved_Without_Sequelae,Resolved,No,Y,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-10-03,2011-10-03,Follow-Up,189.0,189.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-02,2011-11-02,Follow-Up,219.0,219.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-12,2011-11-12,Follow-Up,229.0,229.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-17,2011-11-17,Follow-Up,234.0,234.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-21,2011-11-21,Follow-Up,238.0,238.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Nasal_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-11-28,2011-11-28,Follow-Up,245.0,245.0,0.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Gastrointestinal_disorders,Vomiting,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2011-12-20,2011-12-30,Follow-Up,267.0,277.0,10.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Infections_and_infestations,Kidney_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-03-18,2012-03-28,Follow-Up,356.0,366.0,10.0,No,Unlikely_Related,Unlikely,Grade_1_(Mild),1,None,Infections_and_infestations,Otitis_externa,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-05-19,2012-05-19,Follow-Up,418.0,418.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-04-14,2012-04-14,Follow-Up,383.0,383.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-11-03,2012-11-03,Follow-Up,586.0,586.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Infections_and_infestations,Gastroenteritis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-05,2012-12-05,Follow-Up,618.0,618.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-05,2012-12-14,Follow-Up,618.0,627.0,9.0,No,Unrelated,Unrelated,Grade_2_(Moderate),2,None,Infections_and_infestations,Pharyngitis_streptococcal,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2012-12-31,2012-12-31,Follow-Up,644.0,644.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-01-03,2013-01-03,Follow-Up,647.0,647.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-01-22,2013-01-22,Follow-Up,666.0,666.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-02-07,2013-02-07,Follow-Up,682.0,682.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-02-20,2013-02-20,Follow-Up,695.0,695.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-02-28,2013-02-28,Follow-Up,703.0,703.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-03-10,2013-03-10,Follow-Up,713.0,713.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_820343,SUB228882,N/A,ITN041AI,Part_1a,Pediatric,Alpha-1_Antitrypsin,2011-03-12,2011-03-12,-16.0,2011-03-08,-20.0,2011-03-28,Yes,2011-03-28,Yes,Yes,E/I/S,2011-03-28,2011-06-27,2011-05-02,2011-08-01,2013-04-02,2012-03-19,736.0,Yes,Complete,2013-04-02,736.0,,Yes,2011-08-01,126.0,,8.0,Female,144.5,55.5,26.580141521,White,Multiple_Races,Not_Hispanic_or_Latino,Completed_study_and_therapy,2013-03-18,2013-03-18,Follow-Up,721.0,721.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-04-15,2011-04-15,Low_Dose,31.0,31.0,0.0,No,Unrelated,Unrelated,Grade_1_(Mild),1,None,Psychiatric_disorders,Panic_attack,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-06-08,2011-06-08,High_Dose,85.0,85.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-06-08,2011-06-15,High_Dose,85.0,92.0,7.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-07-08,2011-07-08,Follow-Up,115.0,115.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-08-26,2011-08-26,Follow-Up,164.0,164.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-08-27,2011-08-27,Follow-Up,165.0,165.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-09-10,2011-09-10,Follow-Up,179.0,179.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-09-21,2011-09-21,Follow-Up,190.0,190.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-09-22,2011-09-22,Follow-Up,191.0,191.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-09-26,2011-09-26,Follow-Up,195.0,195.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-09-28,2011-09-28,Follow-Up,197.0,197.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-10-03,2011-10-03,Follow-Up,202.0,202.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-10-06,2011-10-30,Follow-Up,205.0,229.0,24.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Infections_and_infestations,Urinary_tract_infection,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-10-10,2011-10-10,Follow-Up,209.0,209.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-10-29,2011-10-29,Follow-Up,228.0,228.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-11-09,2011-12-18,Follow-Up,239.0,278.0,39.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Skin_and_subcutaneous_tissue_disorders,Urticaria,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-11-26,2011-12-19,Follow-Up,256.0,279.0,23.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Gastrointestinal_disorders,Diarrhoea,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-11-26,2011-11-26,Follow-Up,256.0,256.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-12-02,2011-12-02,Follow-Up,262.0,262.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-12-07,2011-12-07,Follow-Up,267.0,267.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-12-13,2011-12-13,Follow-Up,273.0,273.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-12-16,2011-12-16,Follow-Up,276.0,276.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-12-17,2011-12-17,Follow-Up,277.0,277.0,0.0,No,Possibly_Related,Possibly,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-11-21,2011-12-27,Follow-Up,251.0,287.0,36.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Nervous_system_disorders,Sinus_headache,No,,,Resolved_Without_Sequelae,Resolved,No,Y,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-01-23,2012-01-26,Follow-Up,314.0,317.0,3.0,No,Possibly_Related,Possibly,Grade_1_(Mild),1,None,Respiratory,_thoracic_and_mediastinal_disorders,Nasal_congestion,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2011-10-30,2011-10-30,Follow-Up,229.0,229.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-01-29,2012-03-31,Follow-Up,320.0,382.0,62.0,No,Unlikely_Related,Unlikely,Grade_2_(Moderate),2,None,Eye_disorders,Blepharitis,No,,,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-03-09,2012-03-09,Follow-Up,360.0,360.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-02-20,2012-02-20,Follow-Up,342.0,342.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-02-03,2012-02-03,Follow-Up,325.0,325.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-04-12,2012-04-12,Follow-Up,394.0,394.0,0.0,No,Possibly_Related,Possibly,Grade_3_(Severe),3,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-02-17,2012-02-17,Follow-Up,339.0,339.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-03-24,2012-03-24,Follow-Up,375.0,375.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-03-26,2012-03-26,Follow-Up,377.0,377.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-04-29,2012-04-29,Follow-Up,411.0,411.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-06-02,2012-06-02,Follow-Up,445.0,445.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-06-15,2012-06-15,Follow-Up,458.0,458.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-06-05,2012-06-05,Follow-Up,448.0,448.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-06-16,2012-06-16,Follow-Up,459.0,459.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-06-22,2012-06-22,Follow-Up,465.0,465.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
RETAIN_859067,SUB228883,N/A,ITN041AI,Part_1a,Adult,Alpha-1_Antitrypsin,2011-03-01,2011-03-01,-14.0,2010-12-14,-91.0,2011-03-15,Yes,2011-03-15,Yes,Yes,E/I/S,2011-03-15,2011-05-17,2011-04-19,2011-06-21,2012-06-12,2012-03-13,455.0,No,Terminated_early_from_protocol,2013-03-19,735.0,Failure_to_Return/Lost_to_Follow-Up,Yes,2011-06-21,98.0,,23.0,Female,160.5,48.0,18.633359536,White,Multiple_Races,Unknown,Terminated_from_study,2012-06-25,2012-06-25,Follow-Up,468.0,468.0,0.0,No,Possibly_Related,Possibly,Grade_2_(Moderate),2,None,Metabolism_and_nutrition_disorders,Hypoglycaemia,Yes,,Glucose_less_than_55,Resolved_Without_Sequelae,Resolved,No,,,,,,,,,,,,,2014-06-06,6.0,6.0
